Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
BlueOcean Ventures SA is a venture capital firm founded by Faris Sabeti, Emmanuel de Watteville, Sacha Haymoz, and Thomas Zehnder. Established in Jersey as an investment fund, the firm operates from its headquarters in Geneva, Switzerland. The firm focuses on early-stage investments in medical device and life science companies, particularly in untapped markets across Europe.
Currently, BlueOcean Ventures manages a portfolio of 12 companies, emphasizing sectors such as biotech, healthcare, digital health, and nanotechnologies. The firm has established itself as a key player in the early-stage investment landscape, leveraging a network of industry experts to support its portfolio companies. Notable milestones include the successful development of innovative medical technologies and the establishment of strategic partnerships within the healthcare sector.
BlueOcean Ventures primarily invests in early-stage medical device and diagnostics companies, with a strong emphasis on Switzerland and Europe. The firm seeks to identify highly promising startups that demonstrate significant growth potential. Its investment strategy includes acting as a lead investor or co-investor/syndicator, focusing on large investment amounts.
Pre-money company valuations typically range from CHF 3 to 10 million, allowing BlueOcean Ventures to engage with startups at various stages of development. The firm also maintains a secondary focus on life sciences, digital health, and nanotechnologies, ensuring a diverse investment portfolio. BlueOcean Ventures looks for founders who exhibit strong leadership qualities and a clear vision for their companies, aiming to partner with those who are committed to advancing medical technology.
BlueOcean Ventures has built a diverse portfolio of 12 companies, each contributing to advancements in medical technology and healthcare. Notable portfolio companies include:
Faris Sabeti: Co-Founder and Advisor at BlueOcean Ventures, Faris has extensive experience in venture capital and entrepreneurship, focusing on medical technology investments.
Emmanuel de Watteville: Co-Founder and Advisor, Emmanuel brings a wealth of knowledge in investment strategies and market analysis, particularly in the life sciences sector.
Sacha Haymoz: Advisor with a strong background in healthcare investments, Sacha contributes valuable insights into emerging medical technologies.
Thomas Zehnder: Co-Founder and Advisor, Thomas has a deep understanding of the medical device industry and plays a key role in guiding portfolio companies.
To pitch to BlueOcean Ventures, founders should visit their website at blueocean-ventures.com. The firm prefers detailed pitch decks that include information on the business model, market analysis, and team qualifications. Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are encouraged to facilitate the pitching process.
As of October 2023, BlueOcean Ventures continues to expand its portfolio, focusing on early-stage investments in medical technology. The firm has recently engaged with several promising startups in the healthcare sector, emphasizing its commitment to supporting innovation in untapped markets.
BlueOcean Ventures has also been active in building partnerships with industry experts to enhance the resources available to its portfolio companies. This strategic approach aims to drive growth and success for the startups within its investment portfolio.
What are BlueOcean Ventures' investment criteria?
BlueOcean Ventures invests in early-stage medical device and diagnostics companies, particularly in Switzerland and Europe. The firm focuses on startups with pre-money valuations typically ranging from CHF 3 to 10 million.
How can I apply or pitch to BlueOcean Ventures?
Founders can submit their pitches through the BlueOcean Ventures website at blueocean-ventures.com. The firm encourages detailed presentations that outline the business model, market potential, and team qualifications.
What makes BlueOcean Ventures different from other investors?
BlueOcean Ventures emphasizes early-stage investments in untapped markets, leveraging a vast network of industry experts to support portfolio companies. This approach allows them to provide valuable insights and resources to startups.
What is the geographic scope of BlueOcean Ventures?
The firm primarily focuses on investments in Switzerland and Europe, targeting companies that operate in the medical device and life sciences sectors.
What is the typical check size for investments?
BlueOcean Ventures typically invests in pre-money valuations ranging from CHF 3 to 10 million, allowing for significant capital deployment in promising startups.
What is BlueOcean Ventures' post-investment involvement?
The firm actively engages with its portfolio companies, providing mentorship, operational support, and access to a network of industry experts to help drive growth and success.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.